Breaking News Instant updates and real-time market news.

CLXT

Calyxt

$16.88

-0.3 (-1.75%)

, BAYRY

Bayer

$0.00

(0.00%)

16:42
05/15/18
05/15
16:42
05/15/18
16:42

Bayer CropScience to settle lawsuit filed by Calyxt

Calyxt (CLXT) announced that Bayer CropScience, LP (BAYRY) has agreed to settle a lawsuit brought by Calyxt in the Delaware Chancery Court. Under the settlement terms, the parties agreed that the 2013 License Agreement is terminated, that Bayer will destroy any technology, related product and confidential information covered by the License Agreement, and that Bayer will permanently abandon patent applications that are based on or include data related to the covered technology. This settlement confirms Bayer and its subsidiaries have no access to Calyxt technology or intellectual property.

CLXT

Calyxt

$16.88

-0.3 (-1.75%)

BAYRY

Bayer

$0.00

(0.00%)

  • 18

    May

  • 20

    May

CLXT Calyxt
$16.88

-0.3 (-1.75%)

10/30/17
BMOC
10/30/17
INITIATION
Target $32
BMOC
Outperform
Calyxt initiated with an Outperform at BMO Capital
BMO Capital analyst Kennety Zaslow initiated Calyxt with an Outperform and $32 price target saying it has toe potential to produce disruptive products in the nascent agriculture/crop gene-editing space over the next 10 years.
11/01/17
JEFF
11/01/17
NO CHANGE
Target $27
JEFF
Buy
Calyxt price target raised to $27 from $16 at Jefferies
Jefferies analyst Akshay Jagdale raised his price target for Calyxt to $27 saying that while he wasn't expecting shares to re-rate higher this fast, at current levels the company's pipeline is still being undervalued. Calyxt has scarcity value as the only real pure-play gene editing company focused on the agricultural/consumer industries, Jagdale tells investors in a research note. He keeps a Buy rating on the shares.
12/20/17
LTCO
12/20/17
INITIATION
Target $34.25
LTCO
Buy
Calyxt initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Jon Hickman started Calyxt with a Buy rating and $34.25 price target.
04/02/18
SBSH
04/02/18
NO CHANGE
SBSH
Buy
Citi finds FMC management most bullish on Mid-Atlantic tour
After meeting with senior management teams from Air Products (APD), FMC Corporation (FMC), PQ Group (PQG), Calyxt (CLXT) and AgroFresh Solutions (AGFS), Citi analyst P.J. Juvekar says FMC was the most bullish. FMC management highlighted strength in the company's Ag business and the ongoing integration from the DuPont acquisition, Juvekar tells investors in a research note. The analyst raised his estimates for FMC "across the board" on better Ag execution and calls the stock one of our top three ideas. On Air Products, the analyst is "getting more comfortable with the risk/reward of Chinese coal gasification projects." On PQ Group, Juvekar views the recent share pullback as overdone. The company delivered "two solid consecutive quarters" since the initial public offering and has made strides in reducing debt, the analyst contends.
BAYRY Bayer
$0.00

(0.00%)

12/28/17
ARGS
12/28/17
NO CHANGE
Target $470
ARGS
Buy
Regeneron price target lowered to $470 from $540 at Argus
Argus analyst Jasper Hellweg lowered his price target on Regeneron (REGN) to $470 to reflect some of the recent weakness in the stock, but keeps his Buy rating. Hellweg says that while the company's growth has slowed in recent years, it continues to benefit from sales of Eylea, collaboration agreements with Sanofi (SNY) and Bayer (BAYRY) as well as a strong new product pipeline.
12/29/17
JPMS
12/29/17
NO CHANGE
JPMS
Roche added to Analyst Focus List at JPMorgan
JPMorgan analyst Richard Vosser added Roche (RHHBY) to his firm's Analyst Focus List and keeps an Overweight rating on the shares with a SFR 300 price target. The analyst sees Roche as having the most significant earnings upside potential of any of the European large cap pharma stocks in 2018. He believes the potential of the company's pipeline is being underappreciated at current share levels. His top picks for 2018 are Roche and Bayer (BAYRY).
04/10/18
BMOC
04/10/18
DOWNGRADE
Target $128
BMOC
Market Perform
Monsanto downgraded to Market Perform at BMO Capital on Bayer deal prospects
As reported earlier, BMO Capital analyst Joel Jackson downgraded Monsanto (MON) to Market Perform from Outperform while keeping his $128 price target. Jackson cites the rising likelihood of the acquisition by Bayer (BAYRY) after yesterday's reports of approval of the merger by the U.S. Department of Justice. The analyst notes that since the stock price is now so close to Bayer's takeout price, the isn't "sufficient spread" to support a more bullish rating. In the event of a breakdown of the deal, Jackson sees downside support for the stock around $110 per share.
04/16/18
ARGS
04/16/18
DOWNGRADE
ARGS
Sell
Monsanto downgraded to Sell from Buy at Argus
Argus analyst Bill Selesky issued a double-notch downgrade on Monsanto (MON) to Sell from Buy after the U.S. Justice Department approved its acquisition by Bayer (BAYRY) last week. The analyst says the deal is expected to be further approved by Canadian and Mexican regulators and completed by the end of Q2. As part of the approval, the analyst points to the companies' pledge to sell additional assets even as Monsanto stock trades just below Bayer's acquisition price of $128 per share.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/21/18
08/21
13:17
08/21/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$50.44

-0.99 (-1.92%)

, AMTD

TD Ameritrade

$56.25

-3.91 (-6.50%)

13:16
08/21/18
08/21
13:16
08/21/18
13:16
Recommendations
Charles Schwab, TD Ameritrade, E-Trade, JPMorgan analyst commentary  »

Jefferies says JPMorgan…

SCHW

Charles Schwab

$50.44

-0.99 (-1.92%)

AMTD

TD Ameritrade

$56.25

-3.91 (-6.50%)

ETFC

E-Trade

$59.24

-2 (-3.27%)

JPM

JPMorgan

$116.07

1.45 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 26

    Feb

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/21/18
08/21
13:16
08/21/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEX

Terex

$39.76

0.86 (2.21%)

13:12
08/21/18
08/21
13:12
08/21/18
13:12
Hot Stocks
Terex anticipating multiple years of strong demand in AWP sector »

The company sees Aerial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$7.33

-0.165 (-2.20%)

13:10
08/21/18
08/21
13:10
08/21/18
13:10
Options
Call buyer in Vipshop »

Call buyer in Vipshop.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

LEN

Lennar

$53.42

2.31 (4.52%)

13:05
08/21/18
08/21
13:05
08/21/18
13:05
Options
Lennar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

13:02
08/21/18
08/21
13:02
08/21/18
13:02
Periodicals
Uber names new CFO as it moves forward with 'its long-awaited IPO,' BI says »

Uber has hired Nelson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$2.62

0.03 (1.16%)

13:01
08/21/18
08/21
13:01
08/21/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Rigel Pharmaceuticals »

Rodriguez says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$2.62

0.03 (1.16%)

13:01
08/21/18
08/21
13:01
08/21/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Rigel Pharmaceuticals »

Rigel has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$2.62

0.03 (1.16%)

13:01
08/21/18
08/21
13:01
08/21/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Rigel Pharmaceuticals »

Impact of any Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$2.62

0.03 (1.16%)

13:01
08/21/18
08/21
13:01
08/21/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Rigel Pharmaceuticals »

Rigel CEO says Tavalisse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINC

Premier

$44.25

5.9 (15.38%)

, AMZN

Amazon.com

$1,896.00

20.55 (1.10%)

12:58
08/21/18
08/21
12:58
08/21/18
12:58
Recommendations
Premier, Amazon.com analyst commentary  »

Premier price target…

PINC

Premier

$44.25

5.9 (15.38%)

AMZN

Amazon.com

$1,896.00

20.55 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 05

    Sep

  • 13

    Sep

  • 14

    Sep

SPY

SPDR S&P 500 ETF Trust

$287.17

1.49 (0.52%)

, SPX

S&P 500

$0.00

(0.00%)

12:54
08/21/18
08/21
12:54
08/21/18
12:54
Hot Stocks
Breaking Hot Stocks news story on SPDR S&P 500 ETF Trust, S&P 500 »

S&P 500 rises 0.6% to…

SPY

SPDR S&P 500 ETF Trust

$287.17

1.49 (0.52%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$47.52

-0.78 (-1.61%)

12:50
08/21/18
08/21
12:50
08/21/18
12:50
Periodicals
BHP exec says protectionism will result in higher U.S. prices, Reuters says »

BHP head of marketing and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$320.85

12.35 (4.00%)

, MS

Morgan Stanley

$48.90

0.63 (1.31%)

12:49
08/21/18
08/21
12:49
08/21/18
12:49
Periodicals
Morgan Stanley retained as adviser to Tesla, Gasparino says »

Fox Business…

TSLA

Tesla

$320.85

12.35 (4.00%)

MS

Morgan Stanley

$48.90

0.63 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 29

    Oct

12:45
08/21/18
08/21
12:45
08/21/18
12:45
General news
Dallas Fed's Kaplan: Fed has met its goals »

Dallas Fed's Kaplan:…

M

Macy's

$38.27

0.06 (0.16%)

12:40
08/21/18
08/21
12:40
08/21/18
12:40
Options
Short-term ratio spread opened in Macy's »

Short-term ratio spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

12:35
08/21/18
08/21
12:35
08/21/18
12:35
General news
St Louis Fed study on the openness of the U.S. economy »

St Louis Fed study on the…

CCL

Carnival

$61.51

0.74 (1.22%)

12:30
08/21/18
08/21
12:30
08/21/18
12:30
Hot Stocks
Carnival, Canaveral Port Authority reach agreement on cruise terminal »

Carnival Cruise Line has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

TJX

TJX

$106.24

4.56 (4.48%)

12:28
08/21/18
08/21
12:28
08/21/18
12:28
Recommendations
TJX analyst commentary  »

TJX price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SEAC

SeaChange

$1.67

-1.24 (-42.61%)

12:27
08/21/18
08/21
12:27
08/21/18
12:27
Downgrade
SeaChange rating change  »

SeaChange downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINC

Premier

$44.04

5.69 (14.84%)

12:24
08/21/18
08/21
12:24
08/21/18
12:24
Recommendations
Premier analyst commentary  »

Premier price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 05

    Sep

  • 14

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$287.08

1.4 (0.49%)

12:23
08/21/18
08/21
12:23
08/21/18
12:23
Technical Analysis
Technical Take: SPDR S&P 500 ETF at fresh life highs at midday »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$287.08

1.4 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$31.00

0.875 (2.90%)

12:20
08/21/18
08/21
12:20
08/21/18
12:20
Options
$11M call buyer in Scientific Games as shares bounce »

$11M call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$107.04

0.17 (0.16%)

12:19
08/21/18
08/21
12:19
08/21/18
12:19
Hot Stocks
Microsoft launches AccountGuard initiative to protect American election process »

In an earlier blog post,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.